Adalimumab-induced leukocytoclastic vasculitis in a Crohn's disease patient
- PMID: 33512843
- DOI: 10.1097/MEG.0000000000001945
Adalimumab-induced leukocytoclastic vasculitis in a Crohn's disease patient
References
-
- Sokumbi O, Wetter DA, Makol A, Warrington KJ. Vasculitis associated with tumor necrosis factor-α inhibitors. Mayo Clin Proc. 2012; 87:739–745.
-
- Bernardes C, Carvalho D, Saiote J, Ramos J. Leukocytoclastic vasculitis complicating adalimumab therapy for Crohn’s disease: report of three cases. Gastroenterol Hepatol. 2018; 41:442–443.
-
- Villafranca CM, Belloso RMI, Rodriguez MTB, Olabarrieta SB. Vasculitis por adalimumab en un paciente con enfermedad de Crohn. Gastroenterol Hepatol. 2013; 36:296–297. https://linkinghub.elsevier.com/retrieve/pii/S0210570512003135 . [Accessed 21 August 2020]
-
- Cury DB, de Souza AW, Vianna GA, Odashiro D, Farias A, Moss AC. Cutaneous vasculitis in a patient with crohn’s disease treated with adalimumab. Inflamm Bowel Dis. 2017; 23:E1–E2.
-
- Shivaji UN, Awasthi AK, Aherne R. Cutaneous vasculitis caused by anti-tumor necrosis factor therapy: a case report. Clin Gastroenterol Hepatol. 2016; 14:e1–e2.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical